- $8.01m
- $22.77m
- $56.00m
- 53
- 84
- 11
- 48
Annual income statement for Ryvyl, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.53 | 26.3 | 32.9 | 65.9 | 56 |
Cost of Revenue | |||||
Gross Profit | 3.7 | 16.2 | 16.1 | 25.7 | 22.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.6 | 55.9 | 76.5 | 107 | 79.5 |
Operating Profit | -5.1 | -29.6 | -43.5 | -41.5 | -23.5 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.01 | -35.3 | -49.2 | -52.8 | -25.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.01 | -35.3 | -49.2 | -53.1 | -26.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.01 | -35.3 | -49.2 | -53.1 | -26.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.01 | -35.3 | -49.2 | -53.1 | -26.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.68 | -8.61 | -9.99 | -6.63 | -2.65 |